Cystic Fibrosis Market Research Report by Route of Administration (Inhaled Drugs and Oral Drugs), by Drug Class (Bronchodilators, CFTR Modulators, Mucolytics, and Pancreatic Enzyme Supplements) - Global Forecast to 2025 - Cumulative Impact of COVID-19
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Cystic Fibrosis Market is expected to grow from USD 4,518.34 Million in 2020 to USD 6,794.02 Million by the end of 2025.
2. The Global Cystic Fibrosis Market is expected to grow from EUR 3,961.77 Million in 2020 to EUR 5,957.12 Million by the end of 2025.
3. The Global Cystic Fibrosis Market is expected to grow from GBP 3,522.02 Million in 2020 to GBP 5,295.89 Million by the end of 2025.
4. The Global Cystic Fibrosis Market is expected to grow from JPY 482,222.33 Million in 2020 to JPY 725,094.25 Million by the end of 2025.
5. The Global Cystic Fibrosis Market is expected to grow from AUD 6,561.24 Million in 2020 to AUD 9,865.82 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Cystic Fibrosis to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Route of Administration, the Cystic Fibrosis Market studied across Inhaled Drugs and Oral Drugs.
Based on Drug Class, the Cystic Fibrosis Market studied across Bronchodilators, CFTR Modulators, Mucolytics, and Pancreatic Enzyme Supplements.
Based on Geography, the Cystic Fibrosis Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Cystic Fibrosis Market including AbbVie Inc., Advanced Inhalation Therapies (AIT) Ltd., Alcresta Therapeutics, Inc., AlgiPharma AS, Allergan plc, AstraZeneca plc, Celtaxsys, Inc., Elucigene Diagnostics, F. Hoffmann-La Roche AG, Galapagos NV, Gilead Sciences, Inc., NovaBiotics Ltd, Novartis International AG, Teva Pharmaceutical Industries Ltd, and Vertex Pharmaceuticals, Inc..
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Cystic Fibrosis Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Cystic Fibrosis Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cystic Fibrosis Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cystic Fibrosis Market?
4. What is the competitive strategic window for opportunities in the Global Cystic Fibrosis Market?
5. What are the technology trends and regulatory frameworks in the Global Cystic Fibrosis Market?
6. What are the modes and strategic moves considered suitable for entering the Global Cystic Fibrosis Market?
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Cystic Fibrosis Market is expected to grow from USD 4,518.34 Million in 2020 to USD 6,794.02 Million by the end of 2025.
2. The Global Cystic Fibrosis Market is expected to grow from EUR 3,961.77 Million in 2020 to EUR 5,957.12 Million by the end of 2025.
3. The Global Cystic Fibrosis Market is expected to grow from GBP 3,522.02 Million in 2020 to GBP 5,295.89 Million by the end of 2025.
4. The Global Cystic Fibrosis Market is expected to grow from JPY 482,222.33 Million in 2020 to JPY 725,094.25 Million by the end of 2025.
5. The Global Cystic Fibrosis Market is expected to grow from AUD 6,561.24 Million in 2020 to AUD 9,865.82 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Cystic Fibrosis to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Route of Administration, the Cystic Fibrosis Market studied across Inhaled Drugs and Oral Drugs.
Based on Drug Class, the Cystic Fibrosis Market studied across Bronchodilators, CFTR Modulators, Mucolytics, and Pancreatic Enzyme Supplements.
Based on Geography, the Cystic Fibrosis Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Cystic Fibrosis Market including AbbVie Inc., Advanced Inhalation Therapies (AIT) Ltd., Alcresta Therapeutics, Inc., AlgiPharma AS, Allergan plc, AstraZeneca plc, Celtaxsys, Inc., Elucigene Diagnostics, F. Hoffmann-La Roche AG, Galapagos NV, Gilead Sciences, Inc., NovaBiotics Ltd, Novartis International AG, Teva Pharmaceutical Industries Ltd, and Vertex Pharmaceuticals, Inc..
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Cystic Fibrosis Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Cystic Fibrosis Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cystic Fibrosis Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cystic Fibrosis Market?
4. What is the competitive strategic window for opportunities in the Global Cystic Fibrosis Market?
5. What are the technology trends and regulatory frameworks in the Global Cystic Fibrosis Market?
6. What are the modes and strategic moves considered suitable for entering the Global Cystic Fibrosis Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Drug Class Outlook
3.4. Route of Administration Outlook
3.5. Geography Outlook
3.6. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of Cystic Fibrosis & improved diagnostic technologies
5.1.1.2. Increasing global awareness for Cystic Fibrosis
5.1.1.3. Research & development activities and robust drug development pipeline
5.1.1.4. Favorable initiatives are taken by NGOs, government, and private companies
5.1.2. Restraints
5.1.2.1. Expiring patents and generic drugs
5.1.2.2. Increase in genetic mutation rate
5.1.3. Opportunities
5.1.3.1. Increasing demand from emerging economies
5.1.3.2. Growing strategic collaborations, merger, and acquisition
5.1.4. Challenges
5.1.4.1. High cost involved in treatment and complicated pathophysiology
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL CYSTIC FIBROSIS MARKET, BY ROUTE OF ADMINISTRATION
6.1. Introduction
6.2. Inhaled Drugs
6.3. Oral Drugs
7. GLOBAL CYSTIC FIBROSIS MARKET, BY DRUG CLASS
7.1. Introduction
7.2. Bronchodilators
7.3. CFTR Modulators
7.4. Mucolytics
7.5. Pancreatic Enzyme Supplements
8. AMERICAS CYSTIC FIBROSIS MARKET
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. ASIA-PACIFIC CYSTIC FIBROSIS MARKET
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. South Korea
9.10. Thailand
10. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS MARKET
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom
11. COMPETITIVE LANDSCAPE
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis
11.4. Competitor SWOT Analysis
11.5. Competitive Scenario
11.5.1. Merger & Acquisition
11.5.2. Agreement, Collaboration, & Partnership
11.5.3. New Product Launch & Enhancement
11.5.4. Investment & Funding
11.5.5. Award, Recognition, & Expansion
12. COMPANY USABILITY PROFILES
12.1. AbbVie Inc.
12.2. Advanced Inhalation Therapies (AIT) Ltd.
12.3. Alcresta Therapeutics, Inc.
12.4. AlgiPharma AS
12.5. Allergan plc
12.6. AstraZeneca plc
12.7. Celtaxsys, Inc.
12.8. Elucigene Diagnostics
12.9. F. Hoffmann-La Roche AG
12.10. Galapagos NV
12.11. Gilead Sciences, Inc.
12.12. NovaBiotics Ltd
12.13. Novartis International AG
12.14. Teva Pharmaceutical Industries Ltd
12.15. Vertex Pharmaceuticals, Inc.
13. APPENDIX
13.1. Discussion Guide
13.2. License & Pricing
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Drug Class Outlook
3.4. Route of Administration Outlook
3.5. Geography Outlook
3.6. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of Cystic Fibrosis & improved diagnostic technologies
5.1.1.2. Increasing global awareness for Cystic Fibrosis
5.1.1.3. Research & development activities and robust drug development pipeline
5.1.1.4. Favorable initiatives are taken by NGOs, government, and private companies
5.1.2. Restraints
5.1.2.1. Expiring patents and generic drugs
5.1.2.2. Increase in genetic mutation rate
5.1.3. Opportunities
5.1.3.1. Increasing demand from emerging economies
5.1.3.2. Growing strategic collaborations, merger, and acquisition
5.1.4. Challenges
5.1.4.1. High cost involved in treatment and complicated pathophysiology
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL CYSTIC FIBROSIS MARKET, BY ROUTE OF ADMINISTRATION
6.1. Introduction
6.2. Inhaled Drugs
6.3. Oral Drugs
7. GLOBAL CYSTIC FIBROSIS MARKET, BY DRUG CLASS
7.1. Introduction
7.2. Bronchodilators
7.3. CFTR Modulators
7.4. Mucolytics
7.5. Pancreatic Enzyme Supplements
8. AMERICAS CYSTIC FIBROSIS MARKET
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. ASIA-PACIFIC CYSTIC FIBROSIS MARKET
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. South Korea
9.10. Thailand
10. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS MARKET
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom
11. COMPETITIVE LANDSCAPE
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis
11.4. Competitor SWOT Analysis
11.5. Competitive Scenario
11.5.1. Merger & Acquisition
11.5.2. Agreement, Collaboration, & Partnership
11.5.3. New Product Launch & Enhancement
11.5.4. Investment & Funding
11.5.5. Award, Recognition, & Expansion
12. COMPANY USABILITY PROFILES
12.1. AbbVie Inc.
12.2. Advanced Inhalation Therapies (AIT) Ltd.
12.3. Alcresta Therapeutics, Inc.
12.4. AlgiPharma AS
12.5. Allergan plc
12.6. AstraZeneca plc
12.7. Celtaxsys, Inc.
12.8. Elucigene Diagnostics
12.9. F. Hoffmann-La Roche AG
12.10. Galapagos NV
12.11. Gilead Sciences, Inc.
12.12. NovaBiotics Ltd
12.13. Novartis International AG
12.14. Teva Pharmaceutical Industries Ltd
12.15. Vertex Pharmaceuticals, Inc.
13. APPENDIX
13.1. Discussion Guide
13.2. License & Pricing
LIST OF TABLES
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL CYSTIC FIBROSIS MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY INHALED DRUGS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY ORAL DRUGS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY BRONCHODILATORS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATORS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY MUCOLYTICS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY PANCREATIC ENZYME SUPPLEMENTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. AMERICAS CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. AMERICAS CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. AMERICAS CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. ARGENTINA CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. ARGENTINA CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. BRAZIL CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. BRAZIL CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. CANADA CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. CANADA CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. MEXICO CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. MEXICO CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. UNITED STATES CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. UNITED STATES CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. ASIA-PACIFIC CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. ASIA-PACIFIC CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. ASIA-PACIFIC CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. AUSTRALIA CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. AUSTRALIA CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. CHINA CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. CHINA CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. INDIA CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. INDIA CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. INDONESIA CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. INDONESIA CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. JAPAN CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. JAPAN CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. MALAYSIA CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. MALAYSIA CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. PHILIPPINES CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. PHILIPPINES CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. SOUTH KOREA CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. SOUTH KOREA CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. THAILAND CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. THAILAND CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. FRANCE CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. FRANCE CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. GERMANY CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. GERMANY CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. ITALY CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. ITALY CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. NETHERLANDS CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. NETHERLANDS CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. QATAR CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. QATAR CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. RUSSIA CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. RUSSIA CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. SAUDI ARABIA CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. SAUDI ARABIA CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. SOUTH AFRICA CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. SOUTH AFRICA CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. SPAIN CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. SPAIN CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. UNITED ARAB EMIRATES CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. UNITED ARAB EMIRATES CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. UNITED KINGDOM CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. UNITED KINGDOM CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. GLOBAL CYSTIC FIBROSIS MARKET: SCORES
TABLE 72. GLOBAL CYSTIC FIBROSIS MARKET: BUSINESS STRATEGY
TABLE 73. GLOBAL CYSTIC FIBROSIS MARKET: PRODUCT SATISFACTION
TABLE 74. GLOBAL CYSTIC FIBROSIS MARKET: RANKING
TABLE 75. GLOBAL CYSTIC FIBROSIS MARKET: MERGER & ACQUISITION
TABLE 76. GLOBAL CYSTIC FIBROSIS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 77. GLOBAL CYSTIC FIBROSIS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 78. GLOBAL CYSTIC FIBROSIS MARKET: INVESTMENT & FUNDING
TABLE 79. GLOBAL CYSTIC FIBROSIS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 80. GLOBAL CYSTIC FIBROSIS MARKET: LICENSE & PRICING
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL CYSTIC FIBROSIS MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY INHALED DRUGS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY ORAL DRUGS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY BRONCHODILATORS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATORS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY MUCOLYTICS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY PANCREATIC ENZYME SUPPLEMENTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. AMERICAS CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. AMERICAS CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. AMERICAS CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. ARGENTINA CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. ARGENTINA CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. BRAZIL CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. BRAZIL CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. CANADA CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. CANADA CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. MEXICO CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. MEXICO CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. UNITED STATES CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. UNITED STATES CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. ASIA-PACIFIC CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. ASIA-PACIFIC CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. ASIA-PACIFIC CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. AUSTRALIA CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. AUSTRALIA CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. CHINA CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. CHINA CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. INDIA CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. INDIA CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. INDONESIA CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. INDONESIA CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. JAPAN CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. JAPAN CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. MALAYSIA CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. MALAYSIA CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. PHILIPPINES CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. PHILIPPINES CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. SOUTH KOREA CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. SOUTH KOREA CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. THAILAND CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. THAILAND CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. FRANCE CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. FRANCE CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. GERMANY CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. GERMANY CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. ITALY CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. ITALY CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. NETHERLANDS CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. NETHERLANDS CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. QATAR CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. QATAR CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. RUSSIA CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. RUSSIA CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. SAUDI ARABIA CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. SAUDI ARABIA CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. SOUTH AFRICA CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. SOUTH AFRICA CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. SPAIN CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. SPAIN CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. UNITED ARAB EMIRATES CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. UNITED ARAB EMIRATES CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. UNITED KINGDOM CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. UNITED KINGDOM CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. GLOBAL CYSTIC FIBROSIS MARKET: SCORES
TABLE 72. GLOBAL CYSTIC FIBROSIS MARKET: BUSINESS STRATEGY
TABLE 73. GLOBAL CYSTIC FIBROSIS MARKET: PRODUCT SATISFACTION
TABLE 74. GLOBAL CYSTIC FIBROSIS MARKET: RANKING
TABLE 75. GLOBAL CYSTIC FIBROSIS MARKET: MERGER & ACQUISITION
TABLE 76. GLOBAL CYSTIC FIBROSIS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 77. GLOBAL CYSTIC FIBROSIS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 78. GLOBAL CYSTIC FIBROSIS MARKET: INVESTMENT & FUNDING
TABLE 79. GLOBAL CYSTIC FIBROSIS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 80. GLOBAL CYSTIC FIBROSIS MARKET: LICENSE & PRICING
LIST OF FIGURES
FIGURE 1. GLOBAL CYSTIC FIBROSIS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL CYSTIC FIBROSIS MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL CYSTIC FIBROSIS MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2020 (USD MILLION)
FIGURE 5. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 (USD MILLION)
FIGURE 6. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 7. GLOBAL CYSTIC FIBROSIS MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 8. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 9. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 11. GLOBAL CYSTIC FIBROSIS MARKET: MARKET DYNAMICS
FIGURE 12. GLOBAL CYSTIC FIBROSIS MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 13. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 VS 2025 (%)
FIGURE 14. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 VS 2025 (USD MILLION)
FIGURE 15. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025
FIGURE 16. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY INHALED DRUGS, 2020 VS 2025 (USD MILLION)
FIGURE 17. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY ORAL DRUGS, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2020 VS 2025 (%)
FIGURE 19. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2020 VS 2025 (USD MILLION)
FIGURE 20. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2025
FIGURE 21. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY BRONCHODILATORS, 2020 VS 2025 (USD MILLION)
FIGURE 22. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATORS, 2020 VS 2025 (USD MILLION)
FIGURE 23. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY MUCOLYTICS, 2020 VS 2025 (USD MILLION)
FIGURE 24. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY PANCREATIC ENZYME SUPPLEMENTS, 2020 VS 2025 (USD MILLION)
FIGURE 25. AMERICAS CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 26. AMERICAS CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 27. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 28. ARGENTINA CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 29. BRAZIL CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 30. CANADA CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 31. MEXICO CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 32. UNITED STATES CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 33. ASIA-PACIFIC CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 34. ASIA-PACIFIC CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 35. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 36. AUSTRALIA CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 37. CHINA CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 38. INDIA CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 39. INDONESIA CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 40. JAPAN CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 41. MALAYSIA CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 42. PHILIPPINES CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 43. SOUTH KOREA CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. THAILAND CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 46. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 47. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 48. FRANCE CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 49. GERMANY CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 50. ITALY CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. NETHERLANDS CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. QATAR CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 53. RUSSIA CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 54. SAUDI ARABIA CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 55. SOUTH AFRICA CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 56. SPAIN CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. UNITED ARAB EMIRATES CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. UNITED KINGDOM CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 59. GLOBAL CYSTIC FIBROSIS MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 60. GLOBAL CYSTIC FIBROSIS MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 61. GLOBAL CYSTIC FIBROSIS MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 62. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL CYSTIC FIBROSIS MARKET, BY TYPE
FIGURE 1. GLOBAL CYSTIC FIBROSIS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL CYSTIC FIBROSIS MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL CYSTIC FIBROSIS MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2020 (USD MILLION)
FIGURE 5. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 (USD MILLION)
FIGURE 6. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 7. GLOBAL CYSTIC FIBROSIS MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 8. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 9. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 11. GLOBAL CYSTIC FIBROSIS MARKET: MARKET DYNAMICS
FIGURE 12. GLOBAL CYSTIC FIBROSIS MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 13. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 VS 2025 (%)
FIGURE 14. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 VS 2025 (USD MILLION)
FIGURE 15. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025
FIGURE 16. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY INHALED DRUGS, 2020 VS 2025 (USD MILLION)
FIGURE 17. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY ORAL DRUGS, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2020 VS 2025 (%)
FIGURE 19. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2020 VS 2025 (USD MILLION)
FIGURE 20. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY DRUG CLASS, 2025
FIGURE 21. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY BRONCHODILATORS, 2020 VS 2025 (USD MILLION)
FIGURE 22. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY CFTR MODULATORS, 2020 VS 2025 (USD MILLION)
FIGURE 23. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY MUCOLYTICS, 2020 VS 2025 (USD MILLION)
FIGURE 24. GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY PANCREATIC ENZYME SUPPLEMENTS, 2020 VS 2025 (USD MILLION)
FIGURE 25. AMERICAS CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 26. AMERICAS CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 27. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 28. ARGENTINA CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 29. BRAZIL CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 30. CANADA CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 31. MEXICO CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 32. UNITED STATES CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 33. ASIA-PACIFIC CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 34. ASIA-PACIFIC CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 35. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 36. AUSTRALIA CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 37. CHINA CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 38. INDIA CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 39. INDONESIA CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 40. JAPAN CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 41. MALAYSIA CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 42. PHILIPPINES CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 43. SOUTH KOREA CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. THAILAND CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 46. EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 47. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 48. FRANCE CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 49. GERMANY CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 50. ITALY CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. NETHERLANDS CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. QATAR CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 53. RUSSIA CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 54. SAUDI ARABIA CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 55. SOUTH AFRICA CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 56. SPAIN CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. UNITED ARAB EMIRATES CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. UNITED KINGDOM CYSTIC FIBROSIS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 59. GLOBAL CYSTIC FIBROSIS MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 60. GLOBAL CYSTIC FIBROSIS MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 61. GLOBAL CYSTIC FIBROSIS MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 62. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL CYSTIC FIBROSIS MARKET, BY TYPE
